ThermoGenesis Announces New Integrated Distribution Strategy for Cord Blood Products in Western Europe

RANCHO CORDOVA, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, announced today a new integrated distribution agreement in Europe with Concessus for its cord blood products—the AXP® AutoXpress® (AXP) System and BioArchive® System.

Back to news